Brought to you by 
Alexza Pharmaceuticals nets $47mm from IPO
29 Mar 2006
Executive Summary
Alexza Pharmaceuticals, a biotech with a drug delivery technology and clinical-stage compounds that incorporate it, netted $47mm from its initial public offering in which it sold 6.325mm common shares (including the overallotment) at $8 apiece. When it filed the IPO in December 2005, Alexza had hoped to raise $86.25mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alexza Pharmaceuticals nets $47mm from IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice